Clinical Trial Results:
A Phase II Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Immunogenicity of V212 in Adult Patients with Autoimmune Disease
Summary
|
|
EudraCT number |
2011-002313-11 |
Trial protocol |
SE BE EE DK ES NL |
Global completion date |
26 Feb 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
15 Mar 2019
|
First version publication date |
26 Aug 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
V212-009_CSRSyn_Final Redaction |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.